The DOI matches its Crossref record; 306 of the 306 references it cites were found in a registry or an index.
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Open accessAbstract
Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of patients with ACC based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. We predefined four main clinical questions, which we judged as particularly important for the management of ACC patients and performed systematic literature searches: (A) What is needed to diagnose an ACC by histopathology? (B) Which are the best prognostic markers in ACC? (C) Is adjuvant therapy able to prevent recurrent disease or reduce mortality after radical resection? (D) What is the best treatment option for macroscopically incompletely resected, recurrent or metastatic disease? Other relevant questions were discussed within the group. Selected Recommendations: (i) We recommend that all patients with suspected and proven ACC are discussed in a multidisciplinary expert team meeting. (ii) We recommend that every patient with (suspected) ACC should undergo careful clinical assessment, detailed endocrine work-up to identify autonomous hormone excess and adrenal-focused imaging. (iii) We recommend that adrenal surgery for (suspected) ACC should be performed only by surgeons experienced in adrenal and oncological surgery aiming at a complete en bloc resection (including resection of oligo-metastatic disease). (iv) We suggest that all suspected ACC should be reviewed by an expert adrenal pathologist using the Weiss score and providing Ki67 index. (v) We suggest adjuvant mitotane treatment in patients after radical surgery that have a perceived high risk of recurrence (ENSAT stage III, or R1 resection, or Ki67 >10%). (vi) For advanced ACC not amenable to complete surgical resection, local therapeutic measures (e.g. radiation therapy, radiofrequency ablation, chemoembolization) are of particular value. However, we suggest against the routine use of adrenal surgery in case of widespread metastatic disease. In these patients, we recommend either mitotane monotherapy or mitotane, etoposide, doxorubicin and cisplatin depending on prognostic parameters. In selected patients with a good response, surgery may be subsequently considered. (vii) In patients with recurrent disease and a disease-free interval of at least 12 months, in whom a complete resection/ablation seems feasible, we recommend surgery or alternatively other local therapies. Furthermore, we offer detailed recommendations about the management of mitotane treatment and other supportive therapies. Finally, we suggest directions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–306 of 306
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases
Duregon, E., Volante, M., Bollito, E., Goia, M., Buttigliero, C., Zaggia, B., Berruti, A., Scagliotti, G. V., & Papotti, M. G. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.08.012 · Cited by 59
Self-citationMarty, M., Gaye, D., Perez, P., Auder, C., Nunes, M. L., Ferriere, A., Haissaguerre, M., & Tabarin, A. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1056 · Cited by 59
Sirianni, R., Zolea, F., Chimento, A., Ruggiero, C., Cerquetti, L., Fallo, F., Pilon, C., Arnaldi, G., Carpinelli, G., Stigliano, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2374 · Cited by 58
Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease
Livhits, M. J., Li, N., Yeh, M. W., & Harari, A. (2014) · Surgery · doi:10.1016/j.surg.2014.08.047 · Cited by 58
Khan, T. S., Sundin, A., Juhlin, C., Wilander, E., Öberg, K., & Eriksson, B. K. (2004) · Medical Oncology · doi:10.1385/mo:21:2:167 · Cited by 58
Gratian, L., Pura, J. A., Dinan, M. A., Reed, S. D., Scheri, R. P., Roman, S. A., & Sosa, J. A. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3931-z · Cited by 58
Outcomes after resection of cortisol-secreting adrenocortical carcinoma
Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., Phay, J. E., et al. (2015) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2015.09.020 · Cited by 58
Weissferdt, A., Phan, A. T., Suster, S. M., & Moran, C. A. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31828a96cf · Cited by 58
Surgical Resection of Synchronously Metastatic Adrenocortical Cancer
Dy, B. M., Strajina, V., Cayo, A. K., Richards, M. L., Farley, D. R., Grant, C. S., Harmsen, W. S., Evans, D. B., Grubbs, E. G., Bible, K. C., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3944-7 · Cited by 57
Management of Adrenal Tumors in Pregnancy
Eschler, D. C., Kogekar, N., & Pessah‐Pollack, R. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.006 · Cited by 56
Delivanis, D. A., Bancos, I., Atwell, T. D., Schmit, G. D., Eiken, P. W., Natt, N., Erickson, D. Z., Maraka, S., Young, W. F., & Nathan, M. A. (2017) · Clinical Endocrinology · doi:10.1111/cen.13448 · Cited by 56
Fifteen years of adrenalectomies: impact of specialty training and operative volume
Lindeman, B. M., Hashimoto, D. A., Bababekov, Y. J., Stapleton, S. M., Chang, D. C., Hodin, R. A., & Phitayakorn, R. (2017) · Surgery · doi:10.1016/j.surg.2017.05.024 · Cited by 56
Ronchi, C. L., Sbiera, S., Volante, M., Steinhauer, S., Scott-Wild, V., Altieri, B., Kroiß, M., Bala, M., Papotti, M. G., Deutschbein, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105855 · Cited by 55
Self-citationClinical impact of TP53 alterations in adrenocortical carcinomas
Waldmann, J., Patsalis, N., Fendrich, V., Langer, P., Saeger, W., Chaloupka, B., Ramaswamy, A., Faßnacht, M., Bartsch, D. K., & Slater, E. P. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0868-6 · Cited by 55
Cerquetti, L., Bucci, B., Marchese, R., Misiti, S., Paula, U. D., Miceli, R., Muleti, A., Amendola, D., Piergrossi, P., Brunetti, E., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc.1.1315 · Cited by 55
Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?
Gerry, J. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., Glenn, J. A., Phay, J. E., Keplinger, K. M., Fields, R. C., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5536-1 · Cited by 54
Adjuvant Mitotane in Adrenocortical Carcinoma
Bertherat, J. Y., Coste, J., & BERTAGNA, X. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmc076267 · Cited by 53
Operative intervention for recurrent adrenocortical cancer
Dy, B. M., Wise, K. B., Richards, M. L., Young, W. F., Grant, C. S., Bible, K. C., Rosedahl, J. K., Harmsen, W. S., Farley, D. R., & Thompson, G. B. (2013) · Surgery · doi:10.1016/j.surg.2013.06.033 · Cited by 53
The 'omics' of adrenocortical tumours for personalized medicine
Assié, G., Jouinot, A., & Bertherat, J. Y. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.272 · Cited by 52
Asare, E. A., Wang, T. S., Winchester, D. P., Mallin, K., Kebebew, E., & Sturgeon, C. (2014) · Surgery · doi:10.1016/j.surg.2014.08.018 · Cited by 51
Faggiano, A., Leboulleux, S., Young, J., Schlumberger, M. J., & Baudin, É. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02403.x · Cited by 51
Petersenn, S., Richter, P.-A., Broemel, T., Ritter, C. O., Deutschbein, T., Beil, F.-U., Allolio, B., Faßnacht, M., & _, _. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0916 · Cited by 51
Volante, M., Sperone, P., Bollito, E., Frangipane, E., Rosas, R., Daffara, F., Terzolo, M., Berruti, A., & Papotti, M. G. (2006) · Modern Pathology · doi:10.1038/modpathol.3800683 · Cited by 50
Self-citationAdrenocortical carcinoma and pregnancy: clinical and biological features and prognosis
Abiven, G., Coste, J., Tissier, F., Groussin, L., BILLAUD, L., Dousset, B. E., Goffinet, F., BERTAGNA, X. Y., Bertherat, J. Y., & Raffin‐Sanson, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0412 · Cited by 50
Adrenal surgery in England: better outcomes in high‐volume practices
Palazzo, F. F., Dickinson, A., Phillips, B., Sahdev, A., Bliss, R., Rasheed, A. M., Krukowski, Z. H., & Newell-Price, J. D. C. (2016) · Clinical Endocrinology · doi:10.1111/cen.13021 · Cited by 50
Pinzani, P., Scatena, C., Salvianti, F., Corsini, E., Canu, L., Poli, G., Paglierani, M., Piccini, V., Pazzagli, M., Nesi, G., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1396 · Cited by 49
Nilubol, N., Patel, D., & Kebebew, E. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3283-2 · Cited by 49
Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms
Erickson, L. A., Jin, L., Sebo, T. J., Lohse, C., Pankratz, V. S., Kendrick, M. L., van Heerden, J. A., Thompson, G. B., Grant, C. S., & Lloyd, R. V. (2001) · Endocrine Pathology · doi:10.1385/ep:12:4:429 · Cited by 48
Mihai, R., Iacobone, M., Makay, Ö., Moreno, P., Frilling, A., Kraimps, J., Soriano, A., Villar, J. M., Barczyński, M., Durán, M., et al. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0876-6 · Cited by 47
Self-citationSurgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery
Hermsen, I. G. C., Kerkhofs, T. M. A., den Butter, G., Kievit, J., van Eijck, C. H. J., van Dijkum, E. J. M. N., & Haak, H. R. (2012) · Surgery · doi:10.1016/j.surg.2012.02.005 · Cited by 47
Self-citationHistologic Criteria for Adrenocortical Proliferative Lesions: Value of Mitotic Figure Variability
Blanes, A., & Díaz‐Cano, S. J. (2007) · American Journal of Clinical Pathology · doi:10.1309/mcguq3r4a4wwn3lb · Cited by 46
Role of Radiotherapy in Adrenocortical Carcinoma
Ho, J., Türkbey, B., Edgerly, M., Alimchandani, M., Quezado, M., Camphausen, K. A., Fojo, T., & Kaushal, A. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31829e3221 · Cited by 46
Developing treatment for adrenocortical carcinoma
Kerkhofs, T. M. A., Ettaieb, M. H. T., Hermsen, I. G. C., & Haak, H. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0318 · Cited by 46
Self-citationActual 10‐year survivors following resection of adrenocortical carcinoma
Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Wang, T. S., Glenn, J. A., Phay, J. E., Keplinger, K. M., Fields, R. C., Jin, L. X., et al. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24439 · Cited by 46
Baili, E., Moris, D., Tsilimigras, D. I., Oikonomou, D., Pawlik, T. M., Schizas, D., Papalampros, A., Felekouras, E. S., & Dimitroulis, D. (2018) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2017.0546 · Cited by 46
Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma.
Hermsen, I. G. C., Gelderblom, H. A. J., Kievit, J., Romijn, J. A., & Haak, H. R. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0723 · Cited by 45
Self-citationImpact of Regional Lymph Node Dissection on Disease Specific Survival in Adrenal Cortical Carcinoma
Saade, N., Sadler, C., & Goldfarb, M. R. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1549877 · Cited by 45
Results of adrenal surgery. Data of a Spanish National Survey
Villar, J. M., Moreno, P., Ortega, J., Bollo, E., Ramírez, C. P., Muñoz, N. M., Martínez, C. F., Lanuza, E. D.-A., Sancho, J., del Pino, J. M., et al. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0697-z · Cited by 43
Metastatic Adrenocortical Carcinoma: Results of 56 Pulmonary Metastasectomies in 24 Patients
den Winkel, J. O., Pfannschmidt, J., Muley, T., Grünewald, C., Dienemann, H., Faßnacht, M., & Allolio, B. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.07.088 · Cited by 43
Lu, H., Papathomas, T. G., van Zessen, D. B. H., Palli, I., de Krijger, R. R., van der Spek, P. J., Dinjens, W. N. M., & Stubbs, A. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0216-6 · Cited by 42
Surgical Management of Adrenocortical Carcinoma
Datta, J., & Roses, R. E. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.08.011 · Cited by 42
Surgical Management of Advanced Adrenocortical Carcinoma: A 21-year Population-based Analysis
Tran, T. B., Liou, D. Z., Menon, V. G., & Nissen, N. N. (2013) · The American Surgeon · doi:10.1177/000313481307901033 · Cited by 42
Nelson, D. W., Chang, S., Bandera, B. C., Fischer, T. D., Wollman, R. C., & Goldfarb, M. R. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6510-x · Cited by 42
Ronchi, C. L., Sbiera, S., Leich, E., Tissier, F., Steinhauer, S., Deutschbein, T., Faßnacht, M., & Allolio, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2669 · Cited by 41
Genetic predisposition to endocrine tumors: Diagnosis, surveillance and challenges in care
Petr, E. J., & Else, T. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.08.007 · Cited by 40
Self-citationHescot, S., Amazit, L., Lhomme, M., Travers, S. A. A., DuBow, A., Battini, S., Boulate, G., Namer, I. J., Lombès, A., Kontush, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18968 · Cited by 40
The role of the insulin‐like growth factor system in adrenocortical tumourigenesis
Weber, M. M., Fottner, C., & Wolf, E. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.0300s3069.x · Cited by 39
Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001527 · Cited by 39
Langenhuijsen, J. F., Birtle, A. J., Klatte, T., Porpiglia, F., & Timsit, M. (2015) · European Urology Focus · doi:10.1016/j.euf.2015.12.001 · Cited by 38
Huynh, K. T., Lee, D. Y., Lau, B. J., Flaherty, D. C., Lee, J., & Goldfarb, M. R. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.05.015 · Cited by 38
Reimondo, G., Puglisi, S., Zaggia, B., Basile, V., Saba, L., Perotti, P., Francia, S. D., Volante, M., Zatelli, M. C., Cannavò, S., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0452 · Cited by 38
Self-citationLipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma
Hescot, S., Seck, A., Guérin, M., Cockenpot, F., Huby, T., Broutin, S., Young, J., Paci, A., Baudin, É., & Lombès, M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2080 · Cited by 37
Adrenocortical carcinoma: The influence of large vessel extension
Turbendian, H. K., Strong, V. E. M., Hsu, M., Ghossein, R. A., & Fahey, T. J. (2010) · Surgery · doi:10.1016/j.surg.2010.09.024 · Cited by 37
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism
Russo, M., Scollo, C., Pellegriti, G., Cotta, O. R., Squatrito, S., Frasca, F., Cannavò, S., & Gullo, D. (2016) · Clinical Endocrinology · doi:10.1111/cen.12868 · Cited by 36
Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma
Garinet, S., Nectoux, J., Néou, M., Pasmant, É., Jouinot, A., Sibony, M., Orhant, L., da Fonseca, J. P., Perlemoine, K., Bricaire, L., et al. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0467 · Cited by 36
Comparison of Immunohistochemical Markers in the Differential Diagnosis of Adrenocortical Tumors
Zhang, H., Bu, H., Chen, H., et al. (2008) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e318032cf56 · Cited by 35
Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor
Lucón, A. M., Pereira, M. A. A., Mendonca, B. B., Zerbini, M. C. N., Saldanha, L. B., & Arap, S. (2002) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812002000600002 · Cited by 35
Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma
Baudin, É., Docao, C., Gicquel, C., Vassal, G., Bachelot, A., Penfornis, A., & Schlumberger, M. J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf291 · Cited by 35
Zheng, G., Li, H., Deng, J.-H., Zhang, X., & Wu, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157518 · Cited by 35
Kendrick, M. L., Curlee, K. J., Lloyd, R. V., Farley, D. R., Grant, C. S., Thompson, G. B., Rowland, C. M., Young, W. F., & van Heerden, J. A. (2002) · Surgery · doi:10.1067/msy.2002.128476 · Cited by 34
Sgourakis, G. G., Lanitis, S., Kouloura, A., Zaphiriadou, P., Karkoulias, K., Raptis, D. G., Anagnostara, A., & Caraliotas, C. (2014) · Journal of Investigative Surgery · doi:10.3109/08941939.2014.987886 · Cited by 33
Lee, C. W., Salem, A. I., Schneider, D. F., LEVERSON, G. E., Tran, T. B., Poultsides, G. A., Postlewait, L. M., Maithel, S. K., Wang, T. S., Hatzaras, I. S., et al. (2016) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-016-3262-4 · Cited by 33
Creemers, S. G., Korpershoek, E., Atmodimedjo, P. N., Dinjens, W. N. M., van Koetsveld, P. M., Feelders, R. A., & Hofland, L. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00174 · Cited by 33
Nakajo, M., Jinguji, M., Nakajo, M., Shinaji, T., Nakabeppu, Y., Fukukura, Y., & Yoshiura, T. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1207-3 · Cited by 32
Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
Urup, T. H., Pawlak, W. Z., Petersen, R. H., Pappot, H., Rørth, M. R., & Daugaard, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.229 · Cited by 32
Claps, M., Cerri, S., Grisanti, S., Lazzari, B., Ferrari, V. D., Roca, E., Perotti, P., Terzolo, M., Sigala, S., & Berruti, A. (2017) · Endocrine · doi:10.1007/s12020-017-1428-9 · Cited by 31
Self-citationStigliano (2010) · International Journal of Oncology · doi:10.3892/ijo_00000698 · Cited by 30
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas
Creemers, S. G., van Koetsveld, P. M., van Kemenade, F. J., Papathomas, T. G., Franssen, G. J. H., Dogan, F., Eekhoff, E. M. W., van der Valk, P., de Herder, W. W., Janssen, J. A. M. J. L., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0266 · Cited by 30
A systematic review of palliative bone radiotherapy based on pain relief and retreatment rates
Pin, Y., Paix, A., Fèvre, C. L., Antoni, D., Blondet, C., & Noël, G. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.01.006 · Cited by 30
Cistaro, A., Asabella, A. N., Coppolino, P., Quartuccio, N., Altini, C., Cucinotta, M., Alongi, P., Balma, M., Sanfilippo, S., Buschiazzo, A., et al. (2015) · PubMed · doi:10.1967/s002449910202 · Cited by 29
Alexandraki, K., Kaltsas, G., le Roux, C. W., Faßnacht, M., Ajodha, S. J., Christ‐Crain, M., Akker, S. A., Drake, W. M., Edwards, R., Allolio, B., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03631.x · Cited by 29
Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study
Simon, G., Pattou, F. N., Mirallié, É., Lifante, J. C., Nominé-Criqui, C., Arnault, V., de Calan, L., Caillard, C., Carnaille, B. M. L., Brunaud, L., et al. (2016) · Surgery · doi:10.1016/j.surg.2016.08.058 · Cited by 29
Freire, D. S., Siqueira, S. A. C., Zerbini, M. C. N., WAJCHENBERG, B. L., Corrêa‐Giannella, M. L., Lucón, A. M., & Pereira, M. A. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12174 · Cited by 27
Tripto-Shkolnik, L., Blumenfeld, Z., Bronshtein, M., Salmon, A., & Jaffe, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2839 · Cited by 27
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma
Zini, L., Umberto Capitanio, A., Claudio Jeldres, A., Giovanni Lughezzani, A., Sun, M., Shariat, S. F., Isbarn, H., Arjane, P., Widmer, H., Perrotte, P., et al. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08660.x · Cited by 26
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma
Ardito, A., Massaglia, C., Pelosi, E., Zaggia, B., Basile, V., Brambilla, R., Vigna‐Taglianti, F., Duregon, E., Arena, V., Perotti, P., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0707 · Cited by 26
Self-citationPorpiglia, F., Fiori, C., Daffara, F., Zaggia, B., Ardito, A., Scarpa, R. M., Papotti, M. G., Berruti, A., Scagliotti, G. V., & Terzolo, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0422-4 · Cited by 26
Self-citationPregnancy in Women Previously Treated for an Adrenocortical Carcinoma
de Corbière, P., Ritzel, K., Cazabat, L., Ropers, J., Schott, M., Libé, R., Koschker, A., Leboulleux, S., Deutschbein, T., Cao, C. D., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2341 · Cited by 25
The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma
Panjwani, S. J., Moore, M. D., Gray, K. D., Finnerty, B. M., Beninato, T. M., Brunaud, L., Fahey, T. J., & Zarnegar, R. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6064-3 · Cited by 25
Development of a Pharmacokinetic Model of Mitotane
Kerkhofs, T. M. A., Derijks, L. J. J., Ettaieb, H., den Hartigh, J., Neef, K., Gelderblom, H. A. J., Guchelaar, H., & Haak, H. R. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000102 · Cited by 24
Self-citationThomas, A. J., Habra, M. A., Bhosale, P., Qayyum, A., Ahmed, K., Vicens, R., & Elsayes, K. M. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1603-3 · Cited by 24
Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors
For Comete-Cancer Network, Vezzosi, D., Cao, C. D., Hescot, S., Bertherat, J. Y., Haissaguerre, M., Bongard, V., Drui, D., de la Fouchardière, C., Illouz, F., et al. (2017) · Hormones and Cancer · doi:10.1007/s12672-017-0313-6 · Cited by 23
Pulmonary metastases from adrenal cortical carcinoma: Results of resection
Kwauk, S., & BURT, M. E. (1993) · Journal of Surgical Oncology · doi:10.1002/jso.2930530411 · Cited by 22
Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
on behalf of the German Adrenocortical Carcinoma Study Group, Kroiß, M., Deutschbein, T., Schlötelburg, W., Ronchi, C. L., Neu, B., Müller, H., Quinkler, M. O., Hahner, S., Heidemeier, A., et al. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0260-7 · Cited by 22
Brain Metastasis in Patients With Adrenocortical Carcinoma: A Clinical Series
Burotto, M., Tageja, N., Rosenberg, A. Z., Mahalingam, S., Quezado, M., Velarde, M., Edgerly, M., & Fojo, T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2650 · Cited by 21
Altınmakas, E., Hobbs, B. P., Ye, H., Grubbs, E. G., Perrier, N. D., Prieto, V. G., Lee, J. E., & Ng, C. S. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0915-4 · Cited by 20
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas
Laufs, V., Altieri, B., Sbiera, S., Kircher, S., Steinhauer, S., Beuschlein, F., Quinkler, M. O., Willenberg, H. S., Rosenwald, A., Faßnacht, M., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0788 · Cited by 20
Ettaieb, M. H. T., Duker, J. C., Feelders, R. A., Corssmit, E. P. M., van Oordt, C. W. M. D. H., Timmers, H. J. L. M., Kerstens, M. N., Wilmink, J. W., ZELISSEN, P. M. J., Havekes, B., et al. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0270-5 · Cited by 19
Self-citationAdrenal cortical tumours: 25 years’ experience at the Royal Children's Hospital, Melbourne
McDonnell, C. M., & Zacharin, M. (2003) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2003.00268.x · Cited by 18
Short-term variation in plasma mitotane levels confirms the importance of trough level monitoring
Kerkhofs, T. M. A., Derijks, L. J. J., Ettaieb, M. H. T., Eekhoff, E. M. W., Neef, C., Gelderblom, H. A. J., den Hartigh, J., Guchelaar, H., & Haak, H. R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0388 · Cited by 18
Self-citationRegional Lymphadenectomy for Adrenocortical Carcinoma
Miller, B. S., & Doherty, G. M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182891ee5 · Cited by 17
Canter, D. J., Mallin, K., Uzzo, R. G., Egleston, B. L., Simhan, J., Walton, J., Smaldone, M. C., Master, V. A., Bratslavsky, G., & Kutikov, A. (2013) · PubMed · Cited by 17
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors
Rubin, B., Regazzo, D., Redaelli, M., Mucignat‐Caretta, C., Citton, M., Iacobone, M., Scaroni, C. M., Betterle, C., Mantero, F., Fassina, A., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5257-x · Cited by 17
Adjuvant Mitotane for Adrenocortical Cancer—Working through Uncertainty
Terzolo, M., Faßnacht, M., Ciccone, G., Allolio, B., & Berruti, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0120 · Cited by 16
Self-citationMolecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy
Millis, S. Z., Ejadi, S., & Demeure, M. J. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s34292 · Cited by 14
Diagnosis of Adrenal Disorders
Older, R. A., Moore, A. V., Glenn, J. F., et al. (1984) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(22)01165-4 · Cited by 14
The ENSAT registry: A digital repository supporting adrenal cancer research
Stell, A., & Sinnott, R. (2012) · Studies in health technology and informatics · doi:10.3233/978-1-61499-078-9-207 · Cited by 13
Xiao, W.-J., Zhu, Y., Dai, B., Zhang, H., Shi, G., Shen, Y.-J., Zhu, Y., & Ye, D. (2015) · Oncotarget · doi:10.18632/oncotarget.5831 · Cited by 12
Çiftçi, E., Turgut, B., Çakmakçılar, A., & Ertürk, S. A. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000712 · Cited by 12
Werner, R. A., Kroiß, M., Nakajo, M., Mügge, D. O., Hahner, S., Faßnacht, M., Schirbel, A., Bluemel, C., Higuchi, T., Papp, L., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0970-1 · Cited by 11
Kovach, A. E., Nucera, C., Lam, Q., Nguyen, A., Dias-Santagata, D. C., & Sadow, P. M. (2015) · Discoveries · doi:10.15190/d.2015.32 · Cited by 10
Combining Washout and Noncontrast Data From Adrenal Protocol CT
Ng, C. S., Altınmakas, E., Wei, W., Ghosh, P., Li, X., Grubbs, E. G., Perrier, N. A., Prieto, V. G., Lee, J. E., & Hobbs, B. P. (2018) · Academic Radiology · doi:10.1016/j.acra.2017.12.005 · Cited by 7
Rangel, C., Moreira, G. S., Pais-Costa, S. R., Vieira, E., & Gaio, E. (2012) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2012.08.008 · Cited by 4
Wu, Y., & Tan, C. H. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0654-6 · Cited by 3
Recurrent Adrenocortical Carcinoma
Miccoli, P., & Iacconi, P. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_14 · Cited by 1
Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4
Cited by
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
Self-citationNeuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Fassnacht, M., Assie, G., Baudin, E., Eisenhofer, G., de la Fouchardiere, C., Haak, H. R., de Krijger, R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 436
Self-citationOverview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Metadata
- Authors
- Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10
- Volume
- 179
- Issue
- 4
- Pages
- G1-G46
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2883682970
- Cited by
- 961
- References
- 306
- FWCI
- 76.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.